Skip to main content

Advertisement

Log in

Increased expression of endothelin ETB and angiotensin AT1 receptors in peripheral resistance arteries of patients with suspected acute coronary syndrome

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Patients who experience chest pain, in which ischemic heart disease has been ruled out, still have an increased risk of future ischemic cardiac events and premature death, possibly due to subclinical endothelial dysfunction. A feature of endothelial dysfunction is an increased expression of arterial vasoconstrictor endothelin (ET) and angiotensin (AT) receptors. Our aim was to investigate if the arterial expressions of these receptors are changed in patients with suspected but ruled out acute coronary syndrome (ACS). Small subcutaneous arteries (diameter of 100 µm) were surgically removed in an abdominal biopsy from 12 patients suspicious of ACS (susp ACS), admitted to the medical telemetry unit for chest pain. The vessels were analyzed for their receptor protein expression by quantitative immunohistochemistry using specific antibodies directed against ETA, ETB, AT1, and AT2 receptors. The control group (controls) consisted of eight healthy volunteers matched for age and sex with no previous cardiac illness or medication. The susp ACS group had an increased expression of ETB (by 94%) and AT1 (by 34%) receptors in the smooth muscle cells of resistance arteries as compared to the control group. There were no significant differences in AT2 and ETA receptor expression between the groups. The results indicate that the expression of arterial smooth muscle ETB and AT1 receptors are increased in patients with suspected but ruled out ACS. These receptor changes could be important in the regulation of coronary tone and in the development of atherosclerosis, and may be related to increased cardiovascular risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. McMahon GC, Yates DW, Hollis S (2008) Unexpected mortality in patients discharged from the emergency department following an episode of nontraumatic chest pain. Eur J Emerg Med 15:3–8

    Article  Google Scholar 

  2. Selwyn AP, Kinlay S, Libby P, Ganz P (1997) Atherogenic lipids, vascular dysfunction, and clinical signs of ischemic heart disease. Circulation 95:5–7

    CAS  PubMed  Google Scholar 

  3. Verma S, Anderson TJ (2002) Fundamentals of endothelial function for the clinical cardiologist. Circulation 105:546–549

    Article  CAS  PubMed  Google Scholar 

  4. Szmitko PE, Wang CH, Weisel RD, de Almeida JR, Anderson TJ, Verma S (2003) New markers of inflammation and endothelial cell activation: Part I. Circulation 108:1917–1923

    Article  PubMed  Google Scholar 

  5. Stenman E, Edvinsson L (2004) Cerebral ischemia enhances vascular angiotensin AT1 receptor-mediated contraction in rats. Stroke 35:970–974

    Article  CAS  PubMed  Google Scholar 

  6. Lind H, Adner M, Erlinge D, Brunkwall J, Edvinsson L (1999) Selective increase of the contractile response to endothelin-1 in subcutaneous arteries from patients with essential hypertension. Blood Press 8:9–15

    Article  CAS  PubMed  Google Scholar 

  7. Sullivan ME, Dashwood MR, Thompson CS, Muddle JR, Mikhailidis DP, Morgan RJ (1997) Alterations in endothelin B receptor sites in cavernosal tissue of diabetic rabbits: potential relevance to the pathogenesis of erectile dysfunction. J Urol 158:1966–1972

    Article  CAS  PubMed  Google Scholar 

  8. Ekelund U, Nilsson HJ, Frigyesi A, Torffvit O (2002) Patients with suspected acute coronary syndrome in a university hospital emergency department: an observational study. BMC Emerg Med 2:1

    Article  PubMed  Google Scholar 

  9. Tschudi MR, Luscher TF (1994) Characterization of contractile endothelin and angiotensin receptors in human resistance arteries: evidence for two endothelin and one angiotensin receptor. Biochem Biophys Res Commun 204:685–690

    Article  CAS  PubMed  Google Scholar 

  10. Haynes WG, Strachan FE, Webb DJ (1995) Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation 92:357–363

    CAS  PubMed  Google Scholar 

  11. Ekelund U, Albert U, Edvinsson L, Mellander S (1993) In-vivo effects of endothelin-1 and ETA receptor blockade on arterial, venous and capillary functions in skeletal muscle. Acta Physiol Scand 148:273–283

    Article  CAS  PubMed  Google Scholar 

  12. Seo B, Oemar BS, Siebenmann R, von Segesser L, Luscher TF (1994) Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 89:1203–1208

    CAS  PubMed  Google Scholar 

  13. White DG, Garratt H, Mundin JW, Sumner MJ, Vallance PJ, Watts IS (1994) Human saphenous vein contains both endothelin ETA and ETB contractile receptors. Eur J Pharmacol 257:307–310

    Article  CAS  PubMed  Google Scholar 

  14. Dagassan PH, Breu V, Clozel M, Kunzli A, Vogt P, Turina M, Kiowski W, Clozel JP (1996) Up-regulation of endothelin-B receptors in atherosclerotic human coronary arteries. J Cardiovasc Pharmacol 27:147–153

    Article  CAS  PubMed  Google Scholar 

  15. Hasdai D, Mathew V, Schwartz RS, Smith LA, Holmes DR, Jr., Katusic ZS, Lerman A (1997) Enhanced endothelin-B-receptormediated vasoconstriction of small porcine coronary arteries in diet-induced hypercholesterolemia. Arterioscler Thromb Vasc Biol 17:2737–2743

    CAS  PubMed  Google Scholar 

  16. Haynes WG, Ferro CJ, O’Kane KP, Somerville D, Lomax CC, Webb DJ (1996) Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans. Circulation 93:1860–1870

    CAS  PubMed  Google Scholar 

  17. Batra VK, McNeill JR, Xu Y, Wilson TW, Gopalakrishnan V (1993) ETB receptors on aortic smooth muscle cells of spontaneously hypertensive rats. Am J Physiol 264:C479–C484

    CAS  PubMed  Google Scholar 

  18. Barber DA, Michener SR, Ziesmer SC, Miller VM (1996) Chronic increases in blood flow upregulate endothelin-B receptors in arterial smooth muscle. Am J Physiol 270:H65–H71

    CAS  PubMed  Google Scholar 

  19. Wackenfors A, Emilson M, Ingemansson R, Edvinsson L, Malmsjo M (2004) Ischemic heart disease down-regulates angiotensin type 1 receptor mRNA in human coronary arteries. Eur J Pharmacol 503:147–153

    Article  CAS  PubMed  Google Scholar 

  20. Hayzer DJ, Cicila G, Cockerham C, Griendling KK, Delafontaine P, Ng SC, Runge MS (1994) Endothelin A and B receptors are down-regulated in the hearts of hypertensive rats. Am J Med Sci 307:222–227

    Article  CAS  PubMed  Google Scholar 

  21. Zhang M, Ma H, Wang BS, Zhao YZ (2006) Angiotensin II type 2 receptor gene polymorphisms and cardioprotective role in essential hypertension. Heart Vessels 21:95–101

    Article  PubMed  Google Scholar 

  22. Sasamura H, Nakazato Y, Hayashida T, Kitamura Y, Hayashi M, Saruta T (1997) Regulation of vascular type 1 angiotensin receptors by cytokines. Hypertension 30:35–41

    CAS  PubMed  Google Scholar 

  23. Wang CH, Li SH, Weisel RD, Fedak PW, Dumont AS, Szmitko P, Li RK, Mickle DA, Verma S (2003) C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 107:1783–1790

    Article  CAS  PubMed  Google Scholar 

  24. Savoia C, Touyz RM, Volpe M, Schiffrin EL (2007) Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients. Hypertension 49:341–346

    Article  CAS  PubMed  Google Scholar 

  25. Tsutsumi Y, Matsubara H, Ohkubo N, Mori Y, Nozawa Y, Murasawa S, Kijima K, Maruyama K, Masaki H, Moriguchi Y, Shibasaki Y, Kamihata H, Inada M, Iwasaka T (1998) Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ Res 83:1035–1046

    CAS  PubMed  Google Scholar 

  26. Chassagne C, Eddahibi S, Adamy C, Rideau D, Marotte F, Dubois-Rande JL, Adnot S, Samuel JL, Teiger E (2000) Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension. Am J Respir Cell Mol Biol 22:323–332

    CAS  PubMed  Google Scholar 

  27. Yang BC, Phillips MI, Mohuczy D, Meng H, Shen L, Mehta P, Mehta JL (1998) Increased angiotensin II type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 18:1433–1439

    CAS  PubMed  Google Scholar 

  28. Arun KH, Kaul CL, Ramarao P (2004) High glucose concentration augments angiotensin II mediated contraction via AT1 receptors in rat thoracic aorta. Pharmacol Res 50:561–568

    Article  CAS  PubMed  Google Scholar 

  29. Maharsy WM, Kadi LN, Issa NG, Bitar KM, Der-Boghossian AH, Abrahamian R, Bikhazi AB (2007) Cross-talk related to insulin and angiotensin II binding on myocardial remodelling in diabetic rat hearts. J Renin Angiotensin Aldosterone Syst 8:59–65

    Article  CAS  PubMed  Google Scholar 

  30. Ikeda N, Nakajima R, Tsunoda T, Nakamura M, Sugi K (2007) Insulin resistance and acute coronary syndrome in the young Japanese population have a strong association. Heart Vessels 22:165–169

    Article  PubMed  Google Scholar 

  31. Griendling KK, FitzGerald GA (2003) Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation 108:1912–1916

    Article  PubMed  Google Scholar 

  32. Nickenig G, Harrison DG (2002) The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis. Circulation 105:393–396

    Article  CAS  PubMed  Google Scholar 

  33. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141–1148

    CAS  PubMed  Google Scholar 

  34. Mancini GB, Henry GC, Macaya C, O’Neill BJ, Pucillo AL, Carere RG, Wargovich TJ, Mudra H, Luscher TF, Klibaner MI, Haber HE, Uprichard AC, Pepine CJ, Pitt B (1996) Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 94:258–265

    CAS  PubMed  Google Scholar 

  35. Prasad A, Tupas-Habib T, Schenke WH, Mincemoyer R, Panza JA, Waclawin MA, Ellahham S, Quyyumi AA (2000) Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis. Circulation 101:2349–2354

    CAS  PubMed  Google Scholar 

  36. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A (2000) Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101:948–954

    CAS  PubMed  Google Scholar 

  37. Wilhelmsen L, Rosengren A, Hagman M, Lappas G (1998) “Nonspecific” chest pain associated with high long-term mortality: results from the primary prevention study in Goteborg, Sweden. Clin Cardiol 21:477–482

    Article  CAS  PubMed  Google Scholar 

  38. Meier P, Maillard M, Burnier M (2005) The future of angiotensin II inhibition in cardiovascular medicine. Curr Drug Targets Cardiovasc Haematol Disord 5:15–30

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ivan Dimitrijevic.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dimitrijevic, I., Ekelund, U., Edvinsson, ML. et al. Increased expression of endothelin ETB and angiotensin AT1 receptors in peripheral resistance arteries of patients with suspected acute coronary syndrome. Heart Vessels 24, 393–398 (2009). https://doi.org/10.1007/s00380-008-1136-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-008-1136-8

Key words

Navigation